SEC Form 4 · accession 0001179110-18-006677
RIGEL PHARMACEUTICALS INC · RIGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Raul R Rodriguez
Officer — CEO, President · Director
Period of report
May 9, 2018
Accepted (ET)
May 11, 2018 · 7:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001034842
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $2.11 | May 9, 2018 | A | 450,000 | A | — | Feb 2, 2027 | Common Stock | 450,000 | 450,000 | D |
Explanation of responses
- F1On February 2, 2017 the reporting person was granted an option to purchase 450,000 shares of common stock. The option vested based on the Compensation Committee's determination that one or more pre-established performance conditions had been achieved. On May 9, 2018, the Compensation Committee determined that the performance conditions had been achieved, resulting in full vesting of the option.